Marinus W. Lobbezoo

Endpoints and other considerations in phase I studies of targeted anticancer therapy: Recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT)

Christopher M. Booth, A. Hilary Calvert, Giuseppe Giaccone et al. · European Journal of Cancer · 2007 · 109 citations

Medicine, Oncology, Cancer Pharmacology +15

Design and conduct of phase II studies of targeted anticancer therapy: Recommendations from the task force on methodology for the development of innovative cancer therapies (MDICT)

Christopher M. Booth, A. Hilary Calvert, Giuseppe Giaccone et al. · European Journal of Cancer · 2007 · 73 citations

Medicine, Oncology, Pharmacology +17

Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).

Benjamin Winograd, Epie Boven, Marinus W. Lobbezoo et al. · PubMed · 1992 · 46 citations

Medicine, Oncology, Pharmacology +13

Preclinical phase II studies in human tumor lines: A European multicenter study

Epie Boven, Benjamin Winograd, Øystein Fodstad et al. · European Journal of Cancer and Clinical Oncology · 1988 · 40 citations · Full text

Medicine, Oncology, Pharmacology +12

Opiate receptor interaction of compounds derived from or structurally related to fentanyl

Marinus W. Lobbezoo, W. Soudijn, I. van Wijngaarden · Journal of Medicinal Chemistry · 1981 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11